Live feed06:15:00·51dPRReleasevia Quantisnow+1The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation TrialByQuantisnow·Wall Street's wire, on your screen.LGVN· Longeveron Inc.LLY· Eli Lilly and CompanyNVO· Novo Nordisk A/SVKTX· Viking Therapeutics Inc.Health Care
